In MS, let-7i in patients’ plasma exosomes can suppresses induction of Treg cells by targeting insulin like growth factor 1 receptor (IGF1R) and transforming growth factor beta receptor 1 (TGFBR1) (104). This evidence concerns the gene IGF1R and myeloid sarcoma.